Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Doherty MK, Morris PG. International Journal of Women’s Health. 2015;7:47–58. On page 50, Table 1, Note section, “MTD 2 mg/m2 but 1.4 mg/m2 recommended for subsequent studies”. Should have been included.On page 50, Table 2, the 4th column heading shou...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | International Journal of Women's Health |
| Online Access: | http://www.dovepress.com/corrigendum-eribulin-for-the-treatment-of-metastatic-breast-cance-peer-reviewed-article-IJWH |